PatternsRadar
Sign in

AHCLAnlon Healthcare Limited

NSEASM Stage IBand 5%
25.17INR+0.20 (+0.80%)Close · 20 Nov 2026
29 Oct 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹1,338 CrMarket cap
—P/E (TTM)
48.4%Delivery

Filings & corporate actions

7 results filed
CSV
Next results · Q3 FY27
Expected 29 Jan 2027 – 28 Feb 2027
Estimate: filed 29–59 days after quarter end, last 5 times
2026
  • 29 OctresultsResults · Q2 FY27 · consolidated and standalone+3.1%NSE
  • 19 OctshareholdingShareholding · 30 Sept 2026+0.4%NSE
  • 30 JulresultsResults · Q1 FY27 · consolidated and standalone+0.6%NSE
  • 20 JulshareholdingShareholding · 30 Jun 2026+1.8%NSE
  • 29 MayresultsResults · Q4 FY26 · consolidated and standalone-1.9%NSE
  • 1 MayresultsResults · Q3 FY26 · standalone-1.4%NSE
  • 24 AprbonusBonus issue · factor 2.00+10.2%
  • 24 AprsplitSplit · 5 for 1+10.2%
  • 13 AprresultsResults · Q1 FY26 · standalone+4.5%NSE
  • 11 AprshareholdingShareholding · 31 Mar 2026+2.3%NSE
  • 9 FebresultsResults · Q3 FY26 · standalone-1.2%NSE
  • 7 JanshareholdingShareholding · 31 Dec 2025+0.7%NSE

Reaction to results · all yearsrose on day 0 in 2 of 6 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2729 Oct 2026+3.1%+7.5%—1.3×
Q1 FY2730 Jul 2026+0.6%+0.2%+9.6%1.0×
Q4 FY2629 May 2026-1.9%+1.5%+15.5%0.4×
Q3 FY269 Feb 2026-1.2%-3.2%+1.2%1.1×
Q2 FY2611 Nov 2025-2.7%+9.3%-1.7%0.7×
Q1 FY2611 Nov 2025-2.7%+9.3%-1.7%0.7×
Average-0.8%+4.1%+4.6%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY—
Profit YoY—
Interest cost YoY—
Revenue QoQ+20.6%
Profit QoQ+61.4%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

Open24.83
Day range24.00 – 25.51
52-week range10.40 – 37.24
From 52w high-32.4%
RSI (14)45.2
ATR (14)1.41
Volume48.47L
Avg volume (20D)39.88L
Rel volume1.22×
Volatility (1Y)55.0%
Turnover₹11.9Cr
Traded value (NSE)₹11.9Cr
VWAP24.64
SMA 50 / 20026.61 / 17.01
Price band5%

Delivery percentage

Latest · 20 Nov 202648.4%
20-day avg50.0%
1-year avg53.2%
Percentile (own history)37th
Range10.8–100.0%
Sessions302

Over the last 20 sessions AHCL settled 50.0% of its traded quantity, which is above average for an NSE equity. Its one-year average is 53.2%, so recent sessions are running 3.2 points lower than usual. The latest session ranks higher than 37% of the 302 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.00%
Dividend, trailing 12M₹0.00
Paid every year for0 yr
Shareholders81.4K · +134.7% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy43 days ago

Performance returns

1D1W1M3M6M1Y
Price+0.80%-6.57%+3.37%+75.16%+81.21%+76.01%

Valuation

Market cap₹1,338 Cr
Market cap (NSE)₹1,338 Cr
Free-float cap₹633 Cr
P/E (TTM)—
P/E (NSE)31.8
EPS (TTM)—
P/B5.2
Net margin (TTM)—
Other income / PBT—
ROE—
Debt / equity0.24
Shares outstanding53.15Cr
Listed3 Sept 2025

Ownership

Promoter52.68%
Promoter Δ QoQ0.00 pp
Public47.32%
FII1.00%
DII0.30%
Pledged0.00%

Quarterly results · consolidated

Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)50.987.6105.6
YoY chg———
Net profit (₹ Cr)11.18.317.2
YoY chg———
Net margin21.8%9.5%16.3%
EPS0.230.160.32

Shareholding over time

By quarter

30 Sept 2026 · promoter 52.68% · public 47.32%
2 Sept 2025: promoter 52.68%30 Sept 2025: promoter 52.68%31 Dec 2025: promoter 52.68%31 Mar 2026: promoter 52.68%30 Jun 2026: promoter 52.68%30 Sept 2026: promoter 52.68%
2025-092026-09
  • Promoter
  • Public and others
Promoter
52.68%
Public
47.32%
Promoter change
0.00 pp
Filed
19 Oct 2026
FII
1.00%
DII
0.30%
Promoter pledged
0.00%

Who the public is

Mutual funds
0.00%

0.00 pp QoQ

Insurance
0.06%

0.00 pp QoQ

FPI
0.99%

-0.68 pp QoQ

Retail ≤ ₹2L
15.01%

+3.32 pp QoQ

HNI > ₹2L
14.23%

-0.27 pp QoQ

NRI
1.21%

+0.74 pp QoQ

Bodies corporate
14.82%

-1.91 pp QoQ

Shareholders
81,356

+134.7% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
PUNITKUMAR R RASADIAPromoter · Individual34.98%
MEET ATULKUMAR VACHHANIPromoter · Individual17.70%
SHREE DWARIKADHISH VENTURES LLPCorporate7.53%
BAN LABS PRIVATE LIMITEDCorporate5.27%
LUV NATWARLAL UKANIIndividual1.13%
JAY MAULESHKUMAR UKANIIndividual1.13%
HARSHAD RASIKLAL SHETHIndividual1.01%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Price-band hits

Loading…

Sessions the stock closed at the limit of its daily price band, from NSE's end-of-day list. A stock pinned at the band could not trade past it that day.

Bulk & block deals · 8 Oct 2026

CSV
12 of 131 deals
By year
DateDealClientQuantityPriceValue
8 Oct 2026Sell · bulkNEO APEX SHARE BROKING SERVICES LLP62.72L26.81₹16.8Cr
8 Oct 2026Buy · bulkNEO APEX SHARE BROKING SERVICES LLP54.17L26.78₹14.5Cr
6 Oct 2026Buy · bulkNEO APEX SHARE BROKING SERVICES LLP58.59L29.70₹17.4Cr
6 Oct 2026Sell · bulkNEO APEX SHARE BROKING SERVICES LLP14.21L29.76₹4.2Cr
30 Sept 2026Buy · bulkNEO APEX SHARE BROKING SERVICES LLP52.09L34.66₹18.1Cr
30 Sept 2026Sell · bulkNEO APEX SHARE BROKING SERVICES LLP27.02L34.62₹9.4Cr
29 Sept 2026Sell · bulkNEO APEX SHARE BROKING SERVICES LLP27.50L36.39₹10.0Cr
29 Sept 2026Buy · bulkNEO APEX SHARE BROKING SERVICES LLP17.50L36.39₹6.4Cr
25 Sept 2026Sell · bulkHRTI PRIVATE LIMITED72.45L30.20₹21.9Cr
25 Sept 2026Buy · bulkHRTI PRIVATE LIMITED72.25L30.10₹21.7Cr
25 Sept 2026Sell · bulkNK SECURITIES RESEARCH PRIVATE LIMITED32.98L30.15₹9.9Cr
25 Sept 2026Buy · bulkNK SECURITIES RESEARCH PRIVATE LIMITED32.90L30.13₹9.9Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares bought on broker margin funding (MTF) and still held at the day’s end, and the amount brokers have lent against them.

Exchange surveillance

20 Nov 2026
  • Long-term ASM · Stage I · since 25 Sept 2026 — Long-term Additional Surveillance Measure: after a sustained unusual move, trades carry a higher margin and, at later stages, settle trade-for-trade.

Price band: 5% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
 Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations50.987.6105.6
Other income0.00.10.0
Total income50.987.6105.7
Total expenses36.574.082.2
└ Finance costs0.60.90.9
└ Depreciation0.31.11.0
Profit before tax14.413.723.5
Tax expense3.45.46.3
Net profit11.18.317.2
EPS0.230.160.32
Net margin21.76%9.46%16.27%
PBT margin28.38%15.60%22.23%
Tax rate23.34%39.37%26.82%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 29 Oct 2026.

3 quarters on file; a year-on-year comparison needs five.

Balance sheet & cash flow · half-yearly

₹ crore, as filed

Balance sheet

 FY26H1 FY27
Total assets374.0452.7
Current assets308.3368.8
└ Cash & equivalents4.47.3
└ Other bank balances0.00.0
└ Current investments0.00.7
└ Trade receivables103.7142.8
└ Inventories113.2120.2
Total equity254.8295.6
└ Attributable to owners230.2257.4
└ Non-controlling interest24.638.2
└ Share capital53.2106.3
Borrowings43.772.3
└ Current37.661.7
└ Non-current6.110.6
Trade payables42.230.8
Current liabilities107.6145.2
Total liabilities119.2157.2
Net debt39.364.3
Debt / equity0.170.24
Current ratio2.872.54

Cash flow, year to date

 FY26H1 FY27
Operating cash flow(79.4)(7.9)
└ Capex0.0(28.0)
Free cash flow(79.4)(35.9)
Investing cash flow(36.3)(28.5)
Financing cash flow118.739.4
└ Dividends paid0.00.0
└ Buybacks0.00.0
Net change in cash2.92.9

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

AHCL at a glance

  • AHCL closed at ₹25.17 on 20 Nov 2026, +0.80% on the day, +76.0% over one year, 32.4% below its 52-week high of ₹37.24.
  • Delivery was 48.4% of traded quantity on 20 Nov 2026, the 37th percentile of its own 302 sessions with a reading (20-session average 50.0%, 1-year average 53.2%).
  • Market capitalisation is ₹1,338 crore, with no positive trailing earnings for a P/E.
  • Q2 FY27 results (consolidated, filed 29 Oct 2026): revenue ₹106 crore, net profit ₹17 crore; the price moved +3.1% on the first session after.
  • Promoters held 52.68% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 29 Jan 2027 and 28 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE0Y8W01025
SeriesEQ
Listed3 Sept 2025
IPO price91.00 · band Rs.86 to Rs.91
IPO listing3 Sept 2025
NSE market cap · 17 Nov 2026₹1,359 Cr
Free-float market cap (NSE)₹571 Cr
Shares outstanding (NSE)53.15Cr
History from3 Sept 2025
Sessions302
Turnover rank#965

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.